Sleep & NighttimeExplainer
Lemborexant With Sleep Apnea: What Eight Nights Can Tell Us
The breathing study offers limited reassurance. It cannot settle long-term safety or replace an apnea-treatment plan.
The library
Every article, in one place.
PeriodsComparison
Linzagolix Versus Leuprorelin for Fibroid Bleeding
How early bleeding control differed from the main trial result.
Sleep & NighttimeEvidence check
Melatonin for female shift workers: four checks on a 2026 trial
Check the dosing schedule, days-off sleep results and limits before copying a study regimen.
Bloating & DigestionExplainer
Mirtazapine for Feeling Full Too Soon During Meals
What dyspepsia trials found about eating, symptom scores, weight and sleepiness.
SkinQ&A
Nemolizumab for Prurigo Nodularis: Itch Relief and Skin Clearance Are Different Results
How to read the 16-week trial, the US label and the newer long-term follow-up.
Bladder & Pelvic FloorEvidence check
Orlynvah for bladder infection: four label and trial checks
A restricted U.S. indication and a combined symptom-and-culture endpoint need careful reading.
Odor & SweatEvidence check
4 Checks on the Palm Botox Strength Study
Grip and pinch were measured separately; only half the participants were randomized.
Bladder & Pelvic FloorEvidence check
Estrogen Cream Near the Urethra: Four TAPER Trial Checks
What the application comparison can tell you about preventing repeat UTIs.
Bloating & DigestionEvidence check
4 Checks on the Regulora IBS Hypnotherapy Trial
The timing of the pain measurement changes the answer.
SkinEvidence check
Remibrutinib for Chronic Hives Four Evidence Checks
The diagnosis, response threshold, comparison treatment and bleeding discussion behind Rhapsido.
Odor & SweatComparison
RF microneedling or botulinum toxin for underarm sweat
Small split-underarm trials compare symptom relief, pain and treatment burden. They do not establish permanent sweat control.
PeriodsEvidence check
Sertraline for PMDD: Four Checks Before Discussing Symptom-Onset Dosing
The placebo-controlled trial had mixed results, and its schedule differs from labeled luteal-phase treatment.
